Skip to main content
SpringerLink
Log in

Lymphatic Mapping and Sentinel Lymphadenectomy After Preoperative Therapy for Stage II and III Breast Cancer

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: We evaluated the accuracy of sentinel lymph node dissection (SLND) in patients with stage II and III breast cancer who had received preoperative therapy.

Methods: A prospective clinical trial evaluated 122 patients who had SLND followed by axillary lymph node dissection. Thirty-two women had stage II or III breast cancer and received preoperative doxorubicin-based chemotherapy or paclitaxel and radiotherapy.

Results: A sentinel lymph node (SLN) was identified in 31 (97%) of 32 patients. The SLN predicted the status of the axillary nodes in 30 (97%) of 31 patients. Eighteen (58%) of 31 had metastases in the SLN. Eighteen of 19 patients with axillary metastases had a tumor-positive SLN (sensitivity, 95%; false-negative rate, 5%). Eight (44%) of 18 women with metastases in the SLN also had metastases in 1 or more nonsentinel nodes.

Conclusions: In this relatively small study, the accuracy of SLND in women with stage II or III breast cancer treated with preoperative therapy was similar to that achieved in early-stage breast cancer. If these results are confirmed in a larger cohort, it may be feasible to substitute SLND for routine axillary lymph node dissection in this population. This approach could reduce the morbidity of surgical therapy while preserving the accuracy of axillary staging and maintaining regional control in this high-risk population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Giuliano AE, Kirgan DM, Geunther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391–401.

    Article  PubMed  CAS  Google Scholar 

  2. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222:394–401.

    Article  PubMed  CAS  Google Scholar 

  3. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345–50.

    PubMed  CAS  Google Scholar 

  4. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818–22.

    Article  PubMed  CAS  Google Scholar 

  5. O’Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186:423–7.

    Article  PubMed  CAS  Google Scholar 

  6. Haigh PI, Guiliano AE. Role of sentinel lymph node dissection in breast cancer. Ann Med 2000; 32:51–6.

    Article  PubMed  CAS  Google Scholar 

  7. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998; 339:941–6.

    Article  PubMed  CAS  Google Scholar 

  8. Cox CE, Bass SS, McCann CR, et al. Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med 2000; 51:525–42.

    Article  PubMed  CAS  Google Scholar 

  9. Giuliano AE, Haigh PI, Brennan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18:2553–9.

    PubMed  CAS  Google Scholar 

  10. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227:645–51.

    Article  PubMed  CAS  Google Scholar 

  11. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997; 15:2483–93.

    PubMed  CAS  Google Scholar 

  12. Anderson B, Jewell K, Eary J, et al. Neoadjuvant chemotherapy contraindicates sentinel node mapping in breast cancer (abstract). Proc Am Soc Clin Oncol 1999; 18:71a.

    Google Scholar 

  13. Nason KS, Anderson BO, Byrd DR, et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000; 89:2187–94.

    Article  PubMed  CAS  Google Scholar 

  14. Breslin TM, Cohen L, Sahin A, et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000; 18:3480–6.

    PubMed  CAS  Google Scholar 

  15. Mamounas E, Brown A, Smith R, et al. Sentinel node biopsy following neoadjuvant chemotherapy in breast cancer: results from NSABP B-27. Paper presented at: Society of Surgical Oncology 54th Annual Cancer Symposium; March 15–18, 2001; Washington, DC.

  16. Julian TB, Patel N, Dusi D, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 2001; 182:407–10.

    Article  PubMed  CAS  Google Scholar 

  17. Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 2001; 182:312–5.

    Article  PubMed  CAS  Google Scholar 

  18. Chakravarthy A, Nicholson B, Kelley MC, et al. A pilot study of neoadjuvant paclitaxel and radiation with correlative molecular studies in stage II/III breast cancer. Clin Breast Cancer 2000; 1:68–20.

    Article  PubMed  CAS  Google Scholar 

  19. Fleming ID, Cooper JS, Henson DE, et al, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.

    Google Scholar 

  20. Feezor R, Kasraeian A, Copeland EM, et al. Sequential dermal-peritumoral radiocolloid injection for sentinel node biopsy for breast cancer: the University of Florida experience. Am Surg 2002; 68:684–7.

    PubMed  Google Scholar 

  21. Martin RC, Derossis AM, Fey J, et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery 2001; 130:432–8.

    Article  PubMed  CAS  Google Scholar 

  22. Mamounas EP, Fisher B. Preoperative (neoadjuvant) chemotherapy in patients with breast cancer. Semin Oncol 2001; 4:389–99.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Vanderbilt University Medical Center, Nashville, Tennessee

    Glen C. Balch MD, Suhail K. Mithani BS, Ken R. Richards MD, R. Daniel Beauchamp MD & Mark C. Kelley MD

  2. Vanderbilt University Medical Center, 597 Preston Research Building, 21st Ave. South, Nashville, TN, 37232-6860

    Mark C. Kelley MD

Authors
  1. Glen C. Balch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suhail K. Mithani BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ken R. Richards MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Daniel Beauchamp MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mark C. Kelley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark C. Kelley MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Balch, G.C., Mithani, S.K., Richards, K.R. et al. Lymphatic Mapping and Sentinel Lymphadenectomy After Preoperative Therapy for Stage II and III Breast Cancer. Ann Surg Oncol 10, 616–621 (2003). https://doi.org/10.1245/ASO.2003.05.012

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.05.012

Key Words

Search

Navigation